MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.

Cell death: critical control points. Cell (2004) 22.56

Apoptosis in the pathogenesis and treatment of disease. Science (1995) 20.24

Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol (1999) 8.21

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol (2006) 7.87

Apoptosis in cancer. Carcinogenesis (2000) 5.49

A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med (1992) 5.10

A decade of caspases. Oncogene (2003) 3.55

Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer (2009) 3.45

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res (2007) 2.48

MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol (2011) 2.25

Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease? Lung Cancer (2002) 1.53

Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ (2003) 1.41

Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions. J Clin Invest (2015) 1.24

CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res (2005) 1.20

Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol (1996) 1.19

Cancer therapeutics: Targeting the apoptotic pathway. Crit Rev Oncol Hematol (2013) 1.06

Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk. Carcinogenesis (2012) 0.90

Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial. Breast Cancer Res (2012) 0.90

Caspase 7 influences susceptibility to rheumatoid arthritis. Rheumatology (Oxford) (2007) 0.89

Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun (1999) 0.89

Potentially functional polymorphisms in the CASP7 gene contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS One (2013) 0.85

MicroRNA related polymorphisms and breast cancer risk. PLoS One (2014) 0.85

Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy. Int J Cancer (2015) 0.83

microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples. Cancer Epidemiol Biomarkers Prev (2015) 0.82

Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer. J Thorac Oncol (2011) 0.81

Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population. PLoS One (2013) 0.81

Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype. Urology (2013) 0.79

Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment. Chest (2012) 0.77

Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer. Tumour Biol (2015) 0.77